4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-24-027367
PRESIDENT AND CEO gave up 9,897 shares (to pay taxes)
- PRESIDENT AND CEO acquired 40,639 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin PRESIDENT AND CEO | 2024-11-18 | Option exercise | +6,758 | 5,163,654 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2024-11-18 | Shares withheld for taxes | −1,646 | $6.03 | $9,925 | 5,162,008 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2024-11-18 | Option exercise | +11,781 | 5,173,789 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2024-11-18 | Shares withheld for taxes | −2,869 | $6.03 | $17,300 | 5,170,920 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2024-11-18 | Option exercise | +22,100 | 5,193,020 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2024-11-18 | Shares withheld for taxes | −5,382 | $6.03 | $32,453 | 5,187,638 | D |
| Derivatives | |||||||
| Jiang Wenbin PRESIDENT AND CEO | 2024-11-18 | Option exercise · Restricted Stock Units | −6,758 | 31,546 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2024-11-18 | Option exercise · Restricted Stock Units | −11,781 | 109,961 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2024-11-18 | Option exercise · Restricted Stock Units | −22,100 | 294,673 | D | ||
Loading xslF345X05/form4-11202024_111121.xml…